Clinical trial
Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
NCT02581176 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apixaban as Treatment of Venous Thrombosis in Patients With Cancer: The CAP Study
- Lead sponsor
- University Hospital, Akershus
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- May 31, 2018
- Enrollment
- 300 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.